BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3817152)

  • 1. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanisms of the inotropic action of nonachlazine].
    Kaverina NV; Katsenovich RA; Tkachenko BI; Iunusov ZZ; Ovsiannikov VI
    Farmakol Toksikol; 1985; 48(1):23-7. PubMed ID: 3979531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of obzidan on the indices of gas exchange and the sympathetic-adrenal system in ischemic heart disease patients with different types of circulation].
    Katsenovich RA; Kostko SZ; Kozhinskiĭ VM; Kuchenkova MA
    Ter Arkh; 1984; 56(9):51-3. PubMed ID: 6515548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of adrenoreactive preparations on clinical and haemodynamic parameters in patients with ischaemic heart disease.
    Piatak OA; Yanovskii GV; Lizogub VG
    Cor Vasa; 1991; 33(1):19-25. PubMed ID: 1655353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness of nonachlazine in ischemic heart disease under ambulatory conditions].
    Glezer GA; Shraĭber NM; Pak GP; Moskalenko NP
    Kardiologiia; 1980 Jul; 20(7):53-6. PubMed ID: 7401440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanisms of action of nonachlazine].
    Oganesian NM; Oganesian SS; Varosian MA; Bagramian IG; Barinian SB
    Farmakol Toksikol; 1981; 44(3):283-7. PubMed ID: 7286184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peripheral vasodilators and beta-stimulants in the treatment of the initial stages of chronic circulatory insufficiency].
    Shevchenko VA
    Vrach Delo; 1987 Sep; (9):15-8. PubMed ID: 3424762
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of isoptin on intrahepatic and central hemodynamics in ischemic heart disease].
    Komissarov VA
    Klin Med (Mosk); 1987 Sep; 65(9):64-7. PubMed ID: 3695314
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in selecting the optimal propranolol dose in treating patients with angina pectoris of effort and the comparative effectiveness of inderal, anaprilin and obzidan].
    Romakov AIu; Mazur NA
    Ter Arkh; 1984; 56(9):41-6. PubMed ID: 6515546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of the anti-anginal effect of korinfar].
    Voronkov LG; Sokolov NF
    Farmakol Toksikol; 1988; 51(5):38-41. PubMed ID: 3208884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Certain debatable questions concerning the use of nonachlazine in patients with chronic ischemic heart disease].
    Iagus KhK
    Ter Arkh; 1980; 52(9):97-101. PubMed ID: 7434242
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nonachlazine in solution as an arresting agent in stenocardiac attacks].
    Boĭko SS; Kaverina NV; Liubimov BI; Markova GA; Mitrofanov VS
    Farmakol Toksikol; 1979; 42(3):243-7. PubMed ID: 446702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of nonachlazine in the treatment of chronic ischemic heart disease].
    Evtushenko VI; Zakharov NM; Knysh VI; Martynov VI
    Voen Med Zh; 1979 Mar; (3):59-60. PubMed ID: 452467
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of nonachlazine on systemic hemodynamics and the collateral coronary circulation in acute myocardial ischemia].
    Pilipchuk DB; Berger DIa; Sapozhkov AV
    Farmakol Toksikol; 1980; 43(3):324-7. PubMed ID: 7449970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The pharmacodynamics of proxodolol when administered once and in a course of doses to patients with stenocardia of effort].
    Petrov IN; Rumiantsev AS; Smirnov MV
    Eksp Klin Farmakol; 1994; 57(3):54-7. PubMed ID: 7914123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic effects of ceruletide administered intravenously to coronaropathic patients.
    Martini A; Pacciarini MA; Binaghi G; Repetto S; Brunetta F
    Farmaco Sci; 1982 Aug; 37(8):543-7. PubMed ID: 7128811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of nonachlazine on the echocardiographic parameters in patients with post-infarct cardiosclerosis].
    Iagus KhK
    Ter Arkh; 1980; 52(5):42-6. PubMed ID: 7404363
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental study of the effect of nonachlazine on the metabolism of the ischemic myocardium].
    Sysoliatina NA; Iakushev MP; Sapozhkov AV
    Biull Eksp Biol Med; 1982 Mar; 93(3):48-50. PubMed ID: 6284278
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various aspects of the effects of beta adrenergic receptor blockaders, stimulants and calcium antagonists on the cardiovascular system].
    Katsenovich RA; Kostko SZ
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):57-63. PubMed ID: 4005055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of propranolol in an acute test and a course of treatment in patients with stenocardia].
    Savvateev KL; Desiatnichenko VM; Romakov AIu; Mazur NA
    Ter Arkh; 1988; 60(2):96-101. PubMed ID: 3368872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.